These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 27020041)

  • 1. Effect of 5-HT2A and 5-HT2C receptors on temporal discrimination by mice.
    Halberstadt AL; Sindhunata IS; Scheffers K; Flynn AD; Sharp RF; Geyer MA; Young JW
    Neuropharmacology; 2016 Aug; 107():364-375. PubMed ID: 27020041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 5-HT2A receptor stimulation on the discrimination of durations by rats.
    Asgari K; Body S; Bak VK; Zhang ZQ; Rickard JF; Glennon JC; Fone KC; Bradshaw CM; Szabadi E
    Behav Pharmacol; 2006 Feb; 17(1):51-9. PubMed ID: 16377963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence that the effect of 5-HT2 receptor stimulation on temporal differentiation is not mediated by receptors in the dorsal striatum.
    Body S; Asgari K; Cheung TH; Bezzina G; Fone KF; Glennon JC; Bradshaw CM; Szabadi E
    Behav Processes; 2006 Feb; 71(2-3):258-67. PubMed ID: 16326032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute serotonin 2A receptor activation impairs behavioral flexibility in mice.
    Amodeo DA; Hassan O; Klein L; Halberstadt AL; Powell SB
    Behav Brain Res; 2020 Oct; 395():112861. PubMed ID: 32814148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
    Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
    Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.
    Fantegrossi WE; Gray BW; Bailey JM; Smith DA; Hansen M; Kristensen JL
    Psychopharmacology (Berl); 2015 Mar; 232(6):1039-47. PubMed ID: 25224567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a 5-HT2 receptor agonist, DOI (2,5-dimethoxy-4-iodoamphetamine), and antagonist, ketanserin, on the performance of rats on a free-operant timing schedule.
    Body S; Kheramin S; Ho MY; Miranda F; Bradshaw CM; Szabadi E
    Behav Pharmacol; 2003 Dec; 14(8):599-607. PubMed ID: 14665977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
    Fantegrossi WE; Simoneau J; Cohen MS; Zimmerman SM; Henson CM; Rice KC; Woods JH
    J Pharmacol Exp Ther; 2010 Dec; 335(3):728-34. PubMed ID: 20858706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 5-HT1A and 5-HT2A receptor stimulation on temporal differentiation performance in the fixed-interval peak procedure.
    Asgari K; Body S; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Behav Processes; 2006 Feb; 71(2-3):250-7. PubMed ID: 16098683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of fenfluramine on free-operant timing behaviour: evidence for involvement of 5-HT2A receptors.
    Body S; Kheramin S; Ho MY; Miranda Herrera F; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2004 Nov; 176(2):154-65. PubMed ID: 15103450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behavior: interaction between D1 and 5-HT2A receptors.
    Body S; Cheung TH; Bezzina G; Asgari K; Fone KC; Glennon JC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2006 Dec; 189(3):331-43. PubMed ID: 17051415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detailed Characterization of the In Vitro Pharmacological and Pharmacokinetic Properties of
    Jensen AA; McCorvy JD; Leth-Petersen S; Bundgaard C; Liebscher G; Kenakin TP; Bräuner-Osborne H; Kehler J; Kristensen JL
    J Pharmacol Exp Ther; 2017 Jun; 361(3):441-453. PubMed ID: 28360333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
    Body S; Asgari K; Rickard JF; Zhang Z; Fone KC; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 2005 Sep; 181(2):289-98. PubMed ID: 15864559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.
    Fantegrossi WE; Harrington AW; Eckler JR; Arshad S; Rabin RA; Winter JC; Coop A; Rice KC; Woods JH
    Psychopharmacology (Berl); 2005 Sep; 181(3):496-503. PubMed ID: 15983786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerance and Tachyphylaxis to Head Twitches Induced by the 5-HT2A Agonist 25CN-NBOH in Mice.
    Buchborn T; Lyons T; Knöpfel T
    Front Pharmacol; 2018; 9():17. PubMed ID: 29467649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.
    Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB
    Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist properties of N,N-dimethyltryptamine at serotonin 5-HT2A and 5-HT2C receptors.
    Smith RL; Canton H; Barrett RJ; Sanders-Bush E
    Pharmacol Biochem Behav; 1998 Nov; 61(3):323-30. PubMed ID: 9768567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model.
    Canal CE; Booth RG; Morgan D
    Neuropharmacology; 2013 Jul; 70():112-21. PubMed ID: 23353901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effects of 2,5-dimethoxy-4-iodoamphetamine and D-amphetamine on the ability of rats to discriminate the durations and intensities of light stimuli.
    Hampson CL; Body S; den Boon FS; Cheung TH; Bezzina G; Langley RW; Fone KC; Bradshaw CM; Szabadi E
    Behav Pharmacol; 2010 Feb; 21(1):11-20. PubMed ID: 19949322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.